OBJECTIVE: To characterize leg muscle abnormalities in patients with ALS using MRI, and to correlate MRI with standard neurologic measures of motor neuron dysfunction. METHODS: Eleven ALS patients were studied twice (once at baseline and again after 4 months) and compared with eight normal control subjects. MRI data of the lower extremities were compared with tibialis anterior compound muscle action potential amplitude (CMAPa) and foot dorsiflexion maximal voluntary isometric contraction (MVIC). RESULTS: Muscle MRI was abnormal by visual inspection in six of 11 patients. The mean muscle T1 time and muscle volume were not different in patients compared with normal control subjects (p > 0.1). However, the mean T2 times were increased in the patients compared with normal control subjects (p = 0.009). T1 times did not correlate with CMAPa or MVIC. Muscle volume correlated with MVIC (r = 0.73 to 0.78, p < 0.02) but not with CMAPa (p > 0.05). There was a strong negative correlation (r < -0.8, p < or = 0.01) between muscle T2 time and MVIC and CMAPa. Also, the change in T2 relaxation time correlated with the change in CMAPa as the disease progressed (r = -0.63, p = 0.037). CONCLUSION: Of the MRI characteristics studied, T2 relaxation time was the best indicator of motor neuron dysfunction and may have a role in objective evaluation of motor neuron dysfunction.
OBJECTIVE: To characterize leg muscle abnormalities in patients with ALS using MRI, and to correlate MRI with standard neurologic measures of motor neuron dysfunction. METHODS: Eleven ALSpatients were studied twice (once at baseline and again after 4 months) and compared with eight normal control subjects. MRI data of the lower extremities were compared with tibialis anterior compound muscle action potential amplitude (CMAPa) and foot dorsiflexion maximal voluntary isometric contraction (MVIC). RESULTS: Muscle MRI was abnormal by visual inspection in six of 11 patients. The mean muscle T1 time and muscle volume were not different in patients compared with normal control subjects (p > 0.1). However, the mean T2 times were increased in the patients compared with normal control subjects (p = 0.009). T1 times did not correlate with CMAPa or MVIC. Muscle volume correlated with MVIC (r = 0.73 to 0.78, p < 0.02) but not with CMAPa (p > 0.05). There was a strong negative correlation (r < -0.8, p < or = 0.01) between muscle T2 time and MVIC and CMAPa. Also, the change in T2 relaxation time correlated with the change in CMAPa as the disease progressed (r = -0.63, p = 0.037). CONCLUSION: Of the MRI characteristics studied, T2 relaxation time was the best indicator of motor neuron dysfunction and may have a role in objective evaluation of motor neuron dysfunction.
Authors: Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets Journal: J Neuromuscul Dis Date: 2016-03-03
Authors: Thomas M Jenkins; James J P Alix; Charlotte David; Eilish Pearson; D Ganesh Rao; Nigel Hoggard; Eoghan O'Brien; Kathleen Baster; Michael Bradburn; Julia Bigley; Christopher J McDermott; Iain D Wilkinson; Pamela J Shaw Journal: J Neurol Neurosurg Psychiatry Date: 2017-10-31 Impact factor: 10.154
Authors: Nick S Verber; Stephanie R Shepheard; Matilde Sassani; Harry E McDonough; Sophie A Moore; James J P Alix; Iain D Wilkinson; Tom M Jenkins; Pamela J Shaw Journal: Front Neurol Date: 2019-04-03 Impact factor: 4.003
Authors: Uros Klickovic; Luca Zampedri; Christopher D J Sinclair; Stephen J Wastling; Karin Trimmel; Robin S Howard; Andrea Malaspina; Nikhil Sharma; Katie Sidle; Ahmed Emira; Sachit Shah; Tarek A Yousry; Michael G Hanna; Linda Greensmith; Jasper M Morrow; John S Thornton; Pietro Fratta Journal: Neurology Date: 2019-08-07 Impact factor: 9.910
Authors: Jasper M Morrow; Christopher D J Sinclair; Arne Fischmann; Mary M Reilly; Michael G Hanna; Tarek A Yousry; John S Thornton Journal: Eur Radiol Date: 2014-04-20 Impact factor: 5.315
Authors: Thomas M Jenkins; James J P Alix; Jacob Fingret; Taniya Esmail; Nigel Hoggard; Kathleen Baster; Christopher J McDermott; Iain D Wilkinson; Pamela J Shaw Journal: J Neurol Date: 2019-10-17 Impact factor: 4.849